Stay updated on Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Sign up to get notified when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.

Latest updates to the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0.SummaryDifference13%

- Check35 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

- Check49 days agoChange DetectedUpdated the page version from v3.0.1 to v3.0.2. Removed the old version label and the Back to Top link.SummaryDifference0.8%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.8%

- Check63 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference10%

- Check78 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial Assessing IBI310 Similarity to Ipilimumab
Enter your email address, and we'll notify you when there's something new on the Clinical Trial Assessing IBI310 Similarity to Ipilimumab page.